- Home
- VFF vs CRVO Comparison
VFF vs CRVO Comparison
Compare VFF & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFF
- CRVO
- Stock Information
- Founded
- VFF 1989
- CRVO 2001
- Country
- VFF Canada
- CRVO United States
- Employees
- VFF N/A
- CRVO N/A
- Industry
- VFF
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- VFF
- CRVO Health Care
- Exchange
- VFF Nasdaq
- CRVO Nasdaq
- Market Cap
- VFF 87.5M
- CRVO 95.4M
- IPO Year
- VFF N/A
- CRVO N/A
- Fundamental
- Price
- VFF $0.60
- CRVO $9.11
- Analyst Decision
- VFF Buy
- CRVO Strong Buy
- Analyst Count
- VFF 1
- CRVO 8
- Target Price
- VFF N/A
- CRVO $25.43
- AVG Volume (30 Days)
- VFF 305.0K
- CRVO 13.7M
- Earning Date
- VFF 03-13-2025
- CRVO 03-17-2025
- Dividend Yield
- VFF N/A
- CRVO N/A
- EPS Growth
- VFF N/A
- CRVO N/A
- EPS
- VFF N/A
- CRVO N/A
- Revenue
- VFF $336,181,000.00
- CRVO $9,737,974.00
- Revenue This Year
- VFF $2.13
- CRVO N/A
- Revenue Next Year
- VFF $9.93
- CRVO N/A
- P/E Ratio
- VFF N/A
- CRVO N/A
- Revenue Growth
- VFF 17.71
- CRVO 36.29
- 52 Week Low
- VFF $0.60
- CRVO $1.80
- 52 Week High
- VFF $1.62
- CRVO $25.92
- Technical
- Relative Strength Index (RSI)
- VFF 35.85
- CRVO 59.21
- Support Level
- VFF $0.62
- CRVO $7.13
- Resistance Level
- VFF $0.68
- CRVO $10.72
- Average True Range (ATR)
- VFF 0.04
- CRVO 2.56
- MACD
- VFF -0.01
- CRVO -0.02
- Stochastic Oscillator
- VFF 1.54
- CRVO 45.98
About VFF Village Farms International Inc.
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The Company has identified four operating segments - Produce, Cannabis-Canada, Cannabis-U.S. and Energy. The company makes majority of its revenue from the Produce segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.